Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

907 Results

Drug

bevacizumab

Other Name(s): Avastin® , Mvasi®; Zirabev®; Bambevi®; Abevmy®; Aybintio®; Vegzelma™

Quick Link(s): Drug Monograph, Patient Info Sheet

Nov 2024

Breast Cancer Screening for People at High Risk

Oncologie moléculaire et médecine personnalisée

Regimen

BINIENCO

Cancer Type:

Lung,

Non-Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

binimetinib (Unfunded),

encorafenib (Unfunded)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Feb 2025

Document

Ontario-Cervical-Screening-Program-Recommendations-for-Cervical-Screening-and-Colposcopy-with-HPV-testing.pdf

Feb 2025

Document

Ontario-Cervical-Screening-Program-Transition-Guidance-for-ages-21-24.pdf

Feb 2025

Document

Ontario-Cervical-Screening-Program-Guidance-for-Vaginal-Vault-Testing.pdf

Feb 2025

Ontario Cervical Screening Program

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Status: Current

Mar 2025

Document

OCS2024.pdf

Mar 2025

Pages